Invus Global Management, LLC → City Therapeutics, Inc. CTY

Stake: — Shares: — Class: Common Stock, par value $0.0001 per share

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 6/100

Passive Schedule 13G filer baseline

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other Filings by Invus Global Management, LLC

Filed	Form	Issuer	Stake	Shares
2026-09-17	SCHEDULE 13G	Yarrow Bioscience, Inc.	—	—	view →
2026-07-17	SCHEDULE 13G	Agenus Inc.	—	—	view →
2026-06-15	SCHEDULE 13G	Eloxx Pharmaceuticals, Inc. ELOX	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →